» Articles » PMID: 29659307

Recent Advances in Ultrasound-triggered Therapy

Overview
Journal J Drug Target
Publisher Informa Healthcare
Date 2018 Apr 17
PMID 29659307
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

As a non-invasive and real-time diagnostic technique, ultrasound has provided a novel strategy for targeted treatment. With the rapid development of ultrasonic technique and ultrasound contrast agents (UCAs), spatiotemporally controllable application of ultrasound with or without UCAs makes it possible for site-specific delivery of therapeutic agents and targeted modulation with minimal side effects, which indicated a promising therapy in clinical use. This review will describe the main mechanism of targeted therapy induced by ultrasound briefly, then focus on the current application of ultrasound mediated targeted therapy in various fields including tumour, cardiovascular disease, central nervous system, skeletal muscle system diseases and stem cells therapy. In addition, ongoing challenges of ultrasound-mediated targeted therapy for further research and its clinical use are reviewed.

Citing Articles

Multimodal ultrasound plus tumor markers demonstrates a high value in enhanced diagnosis of breast cancer.

Li N, Li M, Zhou F Am J Transl Res. 2024; 16(10):5497-5506.

PMID: 39544801 PMC: 11558377. DOI: 10.62347/QVCI6027.


Effects of therapeutic ultrasound in patients with knee osteoarthritis: A systematic review and meta-analysis.

Luo Y, Rahmati M, Kazemi A, Liu W, Lee S, Gyasi R Heliyon. 2024; 10(10):e30874.

PMID: 38803857 PMC: 11128881. DOI: 10.1016/j.heliyon.2024.e30874.


Shedding light on ultrasound in action: Optical and optoacoustic monitoring of ultrasound brain interventions.

Karakatsani M, Estrada H, Chen Z, Shoham S, Dean-Ben X, Razansky D Adv Drug Deliv Rev. 2024; 205:115177.

PMID: 38184194 PMC: 11298795. DOI: 10.1016/j.addr.2023.115177.


Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.

Hasan N, Nadaf A, Imran M, Jiba U, Sheikh A, Almalki W Mol Cancer. 2023; 22(1):168.

PMID: 37803407 PMC: 10559482. DOI: 10.1186/s12943-023-01854-3.


Physicochemical Stimulus-Responsive Systems Targeted with Antibody Derivatives.

Mohammadi R, Ghani S, Arezumand R, Farhadi S, Khazaee-Poul Y, Kazemi B Curr Mol Med. 2023; 24(10):1250-1268.

PMID: 37594115 DOI: 10.2174/1566524023666230818093016.